[go: up one dir, main page]

CY1115867T1 - Piperidinone Cyanide CGRP Receptor Competitors - Google Patents

Piperidinone Cyanide CGRP Receptor Competitors

Info

Publication number
CY1115867T1
CY1115867T1 CY20141101020T CY141101020T CY1115867T1 CY 1115867 T1 CY1115867 T1 CY 1115867T1 CY 20141101020 T CY20141101020 T CY 20141101020T CY 141101020 T CY141101020 T CY 141101020T CY 1115867 T1 CY1115867 T1 CY 1115867T1
Authority
CY
Cyprus
Prior art keywords
piperidinone
cyanide
cgrp receptor
cgrp
competitors
Prior art date
Application number
CY20141101020T
Other languages
Greek (el)
Inventor
Ian M Bell
Mark E Fraley
Steven N Gallicchio
Anthony Ginnetti
Helen J Mitchell
Daniel V Paone
Donnette D Staas
Cheng Wang
C Blair Zartman
Heather E Stevenson
Original Assignee
Merck Sharp & Dohme Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11787987.4A external-priority patent/EP2638042B1/en
Application filed by Merck Sharp & Dohme Corp. filed Critical Merck Sharp & Dohme Corp.
Publication of CY1115867T1 publication Critical patent/CY1115867T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση κατευθύνεται σε παράγωγα αζαϊνδανίου καρβοξαμιδίου πιπεριδινόνης του τύπου I τα οποία είναι ανταγωνιστές υποδοχέων CGRP και χρήσιμα στη θεραπευτική αγωγή ή πρόληψη ασθενειών στις οποίες εμπλέκεται το CGRP, όπως ημικρανία. Η εφεύρεση κατευθύνεται επίσης σε φαρμακευτικές συνθέσεις οι οποίες αποτελούνται από αυτές τις ενώσεις και στη χρήση αυτών των ενώσεων και συνθέσεων στην πρόληψη ή θεραπευτική αγωγή τέτοιων ασθενειών στις οποίες εμπλέκεται το CGRP.The present invention is directed to piperidinone azidean carboxamide derivatives of formula I which are CGRP receptor antagonists and useful in the treatment or prevention of diseases involving CGRP, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and to the use of these compounds and compositions in preventing or treating such diseases in which CGRP is involved.

CY20141101020T 2010-11-12 2014-12-09 Piperidinone Cyanide CGRP Receptor Competitors CY1115867T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41307710A 2010-11-12 2010-11-12
US201061425034P 2010-12-20 2010-12-20
EP11787987.4A EP2638042B1 (en) 2010-11-12 2011-11-10 Piperidinone carboxamide azaindane cgrp receptor antagonists

Publications (1)

Publication Number Publication Date
CY1115867T1 true CY1115867T1 (en) 2017-01-25

Family

ID=58457244

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141101020T CY1115867T1 (en) 2010-11-12 2014-12-09 Piperidinone Cyanide CGRP Receptor Competitors

Country Status (1)

Country Link
CY (1) CY1115867T1 (en)

Similar Documents

Publication Publication Date Title
CY1118362T1 (en) Piperidinone Cyanide CGRP Receptor Competitors
CY1120866T1 (en) DNA-PK INHIBITORS
CY1122707T1 (en) HETEROCYCLIC GLUTAMINASE INHIBITORS
CY1122266T1 (en) 3-AMINOCYCLALKYL COMPOUNDS AS ROR-GAMMA-T INHIBITORS AND USES THEREOF
EA201991399A1 (en) AMINOTRIAZOLOPYRIDINE COMPOUNDS AND THEIR APPLICATION IN TREATMENT OF CANCER
CY1118143T1 (en) Heterocyclic compounds useful as PDK1 inhibitors
CY1119714T1 (en) SUSPENSION UNIONS
CY1122610T1 (en) ALKOXY PYRAZOLES AS SOLVENT ACTIVATORS OF WANYLATE CYCLES
CY1119056T1 (en) 2 ', 4', - DIFFluoro-2'-Methyl-Substituted Nucleoside Derivatization as HCV RNA Replication Inhibitors
CY1120881T1 (en) 5-HT3 RECEPTOR COMPETITORS
CY1117200T1 (en) Benzylamine derivatives as suspensions
EA201100750A1 (en) SUBSTITUTED DIOXOPIPERIDINYL-PHTHALIMIDE DERIVATIVES
CY1117122T1 (en) PYRAZOLOSPIRACETONE PRODUCTS FOR USE AS ACETYL-COA CARBOXYLATION INHIBITORS
EA201171081A1 (en) INDOL DERIVATIVES AS AN ANTAGONISTS OF CRTH2 RECEPTOR
UA104489C2 (en) Compounds for the treatment of dyslipidemia and related diseases
CY1117745T1 (en) Heterocyclic compounds and their use as Tyrosine kinase type III regulatory receptors
EA201390163A1 (en) HETEROBICYCLIC DERIVATIVES AS HCV INHIBITORS
CY1112758T1 (en) P2X7R INNOVATIVE COMPETITORS AND THEIR USE
CY1121334T1 (en) MOVEMENT INHIBITOR AURORA A
CY1123494T1 (en) ETEPOAPYLO-KAPBOXAMIDIOY COMPOUNDS AS THS RIPK2 ANASTOLES
EA201300436A8 (en) JOINT CRYSTALS AND SALTS OF CCR3 INHIBITORS
CY1117706T1 (en) OXAZOLINE AND ISAXAZOLINE PRODUCERS AS CRAC REGULATORS
CY1121650T1 (en) ALDOSTERONE SYNTHESIS INHIBITORS
CY1114994T1 (en) PEPPERINYL-PRODUCER AS MODIFIED CHEMICAL RECEPTOR ACTIVITY
CY1121063T1 (en) INHIBITORS OF ALDOSTERONE COMPOSITION